Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Stephen v liu
Sep 27, 2024, 12:43 |
Blog
Stephen V Liu: Great talks on immunotherapy and cell therapy at the 2023 Thomas Shea Clinical Cancer Symposium
Stephen V Liu shared a post on X: "Some great talks on immunotherapy and cell…
Sep 26, 2024, 15:37 |
Blog
Stephen V Liu: Retrospective report on treatment post osimertinib for EGFR NSCLC
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 26, 2024, 15:26 |
Blog
Stephen V Liu: Learned a lot at the head and neck session of the Thomas Shea Symposium
Stephen V Liu shared a post on X: ''Learned a lot at the head and…
Sep 26, 2024, 14:05 |
Blog
Stephen V Liu: Real-world study of first-line nivolumab and ipilimumab for pleural mesothelioma
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 25, 2024, 14:41 |
Blog
Stephen V Liu: Opening session of the 2024 Thomas Shea Clinical Cancer Symposium
Stephen V Liu posted on X: "Opening session of the 2024 Thomas Shea Clinical Cancer…
Sep 25, 2024, 14:39 |
Blog
Stephen V Liu: Stephen R Broderick guides a discussion on early stage NSCLC at DCLung24
Stephen V Liu posted on X: "Stephen R Broderick guides a discussion on early stage…
Sep 24, 2024, 11:04 |
Blog
Stephen V Liu: The recent FDA approval of the MARIPOSA-2 regimen for EGFR NSCLC
Stephen V Liu shared a post on X: ''In this episode of the IASLC podcast…
Sep 20, 2024, 13:27 |
Blog
Stephen V Liu: FDA approved MARIPOSA2
Stephen V Liu shared on X: “FDA approved MARIPOSA2: amivantamab plus chemotherapy for EGFR NSCLC…
Sep 18, 2024, 13:28 |
Blog
Stephen V Liu: An impactful ESMO24
Stephen V Liu shared on X: "An impactful ESMO24 - attending keeps you current with…
Sep 17, 2024, 15:07 |
Blog
Stephen V Liu: Data from ARROS-1 study of NVL-520 in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Benjamin Besse presents data from ARROS-1 study…
1
2
3
4
5
All:
233
Posts:
21 - 30
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube